Component
Experimental arginine-depleted culture medium
Study-scoped entity; inspect species, exposure and experimental limitations on each claim.
5 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Arginine removal lowered CD3-zeta and proliferation; replacing arginine reversed the changes.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Jurkat T cells in arginine-free culture medium.
- limitations
- Not a clinical dietary-deficiency threshold.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- The receptor’s signaling machinery could recover when arginine returned.
- primary_references
- Regulation of T cell receptor CD3zeta chain expression by L-arginine. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11950832/ · DOI 10.1074/jbc.m110675200
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 278–284
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Jurkat T cells in arginine-free culture medium. · source_derived_draft · unverified_draft
## arg-jurkat-protein The receptor’s signaling machinery could recover when arginine returned. Arginine removal lowered CD3-zeta and proliferation; replacing arginine reversed the changes. Model: Jurkat T cells in arginine-free culture medium. Limitations: Not a clinical dietary-deficiency threshold. Evidence access: Primary abstract Regulation of T cell receptor CD3zeta chain expression by L-arginine. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11950832/ · DOI 10.1074/jbc.m110675200
Complete structured claim and evidenceArginine removal shortened CD247 mRNA half-life without reducing its transcription rate.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Jurkat T cells in arginine-free culture medium.
- limitations
- Cell-line result; primary T cells showed a different regulatory level in the later study.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- Low availability changed how long an immune-signaling message survived.
- primary_references
- Regulation of T cell receptor CD3zeta chain expression by L-arginine. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11950832/ · DOI 10.1074/jbc.m110675200
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 270–276
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Jurkat T cells in arginine-free culture medium. · source_derived_draft · unverified_draft
## arg-jurkat-rna Low availability changed how long an immune-signaling message survived. Arginine removal shortened CD247 mRNA half-life without reducing its transcription rate. Model: Jurkat T cells in arginine-free culture medium. Limitations: Cell-line result; primary T cells showed a different regulatory level in the later study. Evidence access: Primary abstract Regulation of T cell receptor CD3zeta chain expression by L-arginine. · 2002 · https://pubmed.ncbi.nlm.nih.gov/11950832/ · DOI 10.1074/jbc.m110675200
Complete structured claim and evidenceActivated human T cells failed to restore CD3-zeta in arginine-free medium; replenishment restored expression.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Activated human T-lymphocyte culture.
- limitations
- Unlike Jurkat findings, lower mRNA, greater degradation and apoptosis did not explain this result. Model difference is retained.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- Availability affected rebuilding the receptor after stimulation.
- primary_references
- L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15922712/ · DOI 10.1016/j.cellimm.2005.01.004
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 286–292
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Activated human T-lymphocyte culture. · source_derived_draft · unverified_draft
## arg-primary-cd3 Availability affected rebuilding the receptor after stimulation. Activated human T cells failed to restore CD3-zeta in arginine-free medium; replenishment restored expression. Model: Activated human T-lymphocyte culture. Limitations: Unlike Jurkat findings, lower mRNA, greater degradation and apoptosis did not explain this result. Model difference is retained. Evidence access: Primary abstract L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15922712/ · DOI 10.1016/j.cellimm.2005.01.004
Complete structured claim and evidenceIFN-gamma, IL-5 and IL-10 output decreased, whereas IL-2 did not show the same decrease.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Activated human T-lymphocyte culture.
- limitations
- Not evidence that all cytokines or all immune functions decline together.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- The immune response changed selectively.
- primary_references
- L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15922712/ · DOI 10.1016/j.cellimm.2005.01.004
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 294–300
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Activated human T-lymphocyte culture. · source_derived_draft · unverified_draft
## arg-primary-cytokines The immune response changed selectively. IFN-gamma, IL-5 and IL-10 output decreased, whereas IL-2 did not show the same decrease. Model: Activated human T-lymphocyte culture. Limitations: Not evidence that all cytokines or all immune functions decline together. Evidence access: Primary abstract L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15922712/ · DOI 10.1016/j.cellimm.2005.01.004
Complete structured claim and evidence
Where it participates (unsigned role)
CASTOR1 was required for arginine deprivation to inhibit mTORC1.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Mammalian-cell signaling experiments and biochemical CASTOR1 binding.
- limitations
- Experimental starvation response; no universal dietary cutoff.
- nutrient_topic
- L-Arginine collection; tissue, species, dose and formulation distinctions retained. · L-Arginine
- plain_language
- Low arginine is sensed through specific machinery.
- primary_references
- The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26972053/ · DOI 10.1016/j.cell.2016.02.035
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
L-Arginine: transport, metabolic branches, nutrient interactions, availability and discovery questions (2026-09-18) · lines 190–196
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mammalian-cell signaling experiments and biochemical CASTOR1 binding. · source_derived_draft · unverified_draft
## arg-castor-starvation Low arginine is sensed through specific machinery. CASTOR1 was required for arginine deprivation to inhibit mTORC1. Model: Mammalian-cell signaling experiments and biochemical CASTOR1 binding. Limitations: Experimental starvation response; no universal dietary cutoff. Evidence access: Primary abstract The CASTOR Proteins Are Arginine Sensors for the mTORC1 Pathway. · 2016 · https://pubmed.ncbi.nlm.nih.gov/26972053/ · DOI 10.1016/j.cell.2016.02.035
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.